June 24, 2014 -
Valencell has been granted two new patents by the United States Patent and Trademark Office, both of which relate to the accuracy for next-generation performance biometric data sensors.
With these new two patents, Valencell now has a portfolio of 14 critical patents on its optomechanical approach to biometric measurements for any form factor, as well as more than 45 patents pending.
“We have dedicated years of research and development efforts to establishing a robust intellectual property portfolio of critical patents,” said Dr. Steven LeBoeuf, president of Valencell. “We say our patents are critical, because without our inventions, accurately measuring biometrics during exercise with audio earbuds and other wearables would not be feasible. Our optomechanical technology enables the most accurate optical measurement of biometric data, in any form factor, in any environment, and during all levels of activity – even strenuous exercise. These most recent patents support our extensive product roadmap as brands look to enhance or expand their product and service offerings.”
U.S. Pat. No. 8,702,607, “Targeted advertising systems and methods,” issued April 22, 2014 relates to systems and methods for monitoring a range of physiological and environmental factors with wearable devices and presenting advertisements based on health assessments.
This patented technology will enable companies to advertise to people who may not even be aware that they are at a health risk.
U.S. Pat. No. 8,700,111, “Light-guiding devices and monitoring devices incorporating same,” which was issued April 15, 2014, involves monitoring devices that feature light guides embedded within earbuds.
This patented technology enables the accurate optical monitoring of biometric information even during intense exercise.
There are currently four wearable products in the market that are powered by Valencell’s PerformTek technology, including the LG Heart Rate Earphones, the Scosche Rhythm+ and Smart+ armbands, and the iriverON sports headset.
The company plans to launch more fitness products this year that offer the wide range of PerformTek sensor applications.
Previously reported by BiometricUpdate.com, Valencell has secured more than $7 million in Series C financing, as well as named Michael Dering its new CEO.